MiR-492: A Potent Oncological Biomarker

Authors

  • Priya Rani PG Med. Pharmacology, Department of Pharmacology, National Institute of Medical Sciences & Research, NIMS University, Jaipur, Rajasthan, India. https://orcid.org/0000-0002-6202-5700
  • Shobhit Raj Department of Pharmacy Practice, National Institute of Medical Sciences & Research, NIMS University, Jaipur, Rajasthan, India.
  • Prashant Singh Department of Pharmaceutics, Buddha Institute of Pharmacy, GIDA, Gorakhpur, Uttar Pradesh, India.
  • Ranjeet Kumar Department of Pharmacy Practice, National Institute of Medical Sciences & Research, NIMS University, Jaipur, Rajasthan, India.
  • Manjula Bhargava Department of Pharmacology, National Institute of Medical Sciences & Research, NIMS University, Jaipur, Rajasthan, India.

Keywords:

MiR-492, Oncotherapeutics, Cancer Therapy, Cancer Biomarker

Abstract

Recent studies contribute to an analysis of microRNAs’ roles in health and disease and their potential involvement as biomarkers in physiological and pathophysiological processes, including initiation and development of cancer. Encoded with pseudogene, MiR-492 plays a crucial role in particular cells and over-expression in tissue. It has been proposed as a biomarker to manage and diagnose certain cancers, including breast, colorectal, cervical, hepatocellular, retinoblastoma and pancreas cancer, in the early stages. The purpose of this analysis was to summarise MiR-492 evidence to diagnose and treat certain types of similar cancers early.

How to cite this article: Rani P, Raj S, Singh P et al. MiR-492: A Potent Oncological Biomarker. Int J Adv Res Pharm Edu 2020; 2(2): 24-29.

Downloads

Published

2024-03-01

Issue

Vol. 2 No. 2 (2020): International Journal of Advanced Research in Pharmacy and Education

Section

Review Article